These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38004713)

  • 1. Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study.
    Martín-Iguacel R; Pericas C; Bruguera A; Rosell G; Martínez E; Díaz Y; Alonso L; Nomah DK; Blanco JL; Domingo P; Álvarez-López P; Linares MS; Vilades Laborda C; Mera A; Calzado Isbert S; Johansen IS; Miró JM; Casabona J; Llibre JM;
    Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mpox in people living with HIV.
    Maan I; Kohli M; Gilson R
    Curr Opin Infect Dis; 2024 Feb; 37(1):1-7. PubMed ID: 38112084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mpox in People With Human Immunodeficiency Virus: Predictors of Diagnosis, Outcomes, and Vaccine Effectiveness in a Multisite Cohort.
    Montaño M; Shapiro AE; Whitney BM; Bamford L; Burkholder G; Cachay ER; Christopoulos KA; Crane HM; Delaney JAC; Eron JJ; Fredericksen RJ; Hunt PW; Jacobson JM; Keruly JC; Kim HN; Mayer KH; Moore RD; Napravnik S; Pettit A; Saag MS; Yendewa GA; Kitahata MM; Bender Ignacio RA
    Clin Infect Dis; 2024 Oct; ():. PubMed ID: 39377755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral blips and virologic failures following mpox vaccination with MVA-BN among people with HIV.
    Raccagni AR; Diotallevi S; Lolatto R; Lucente MF; Candela C; Gianotti N; Trentacapilli B; Canetti D; Castagna A; Nozza S
    AIDS; 2023 Dec; 37(15):2365-2369. PubMed ID: 37773029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing Indicators of Engagement in HIV-Associated Healthcare and Clinical Outcomes among People with HIV and Mpox in Washington, DC: A Nested Case-Control Study of the DC Cohort.
    O'Connor LF; Byrne M; Baskaran A; Andersen EW; Horberg MA; Benator DA; Lucar J; Denyer RV; Lee R; Castel AD; Monroe AK;
    Pathogens; 2024 Jan; 13(2):. PubMed ID: 38392854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between HIV and Severe Mpox in an Atlanta Cohort.
    Aldred B; Scott JY; Aldredge A; Gromer DJ; Anderson AM; Cartwright EJ; Colasanti JA; Hall B; Jacob JT; Kalapila A; Kandiah S; Kelley CF; Lyles RH; Marconi VC; Nguyen ML; Rebolledo PA; Sheth AN; Szabo B; Titanji BK; Wiley Z; Workowski K; Cantos VD
    J Infect Dis; 2024 Mar; 229(Supplement_2):S234-S242. PubMed ID: 38001044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mpox severity and associated hospitalizations among people with HIV and related immunosuppression in Brazil.
    Silva MST; Coutinho C; Torres TS; Peixoto EM; Bastos MO; Mesquita MB; Tavares ICF; Andrade HB; Reges PPS; Martins PS; Echeverría-Guevara A; Moreira RI; Lessa FCS; Hoagland B; Nunes EP; Cardoso SW; Veloso VG; Grinsztejn B;
    AIDS; 2024 Jan; 38(1):105-113. PubMed ID: 37812389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain.
    Nomah DK; Reyes-Urueña J; Alonso L; Díaz Y; Moreno-Fornés S; Aceiton J; Bruguera A; Martín-Iguacel R; Imaz A; Gutierrez MDM; Román RW; Suanzes P; Ambrosioni J; Casabona J; Miro JM; Llibre JM; The Piscis Study Group
    Vaccines (Basel); 2023 Dec; 12(1):. PubMed ID: 38250857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mpox Awareness, Risk Reduction, and Vaccine Acceptance among People with HIV in Washington, DC.
    Andersen EW; Kulie P; Castel AD; Lucar J; Benator D; Greenberg AE; Monroe A;
    Pathogens; 2024 Jan; 13(2):. PubMed ID: 38392862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With Mpox.
    Garneau WM; Jones JL; Dashler GM; Mostafa HH; Judson SD; Kwon N; Hamill MM; Gilliams EA; Rudolph DS; Keruly JC; Fall A; Klein EY; Hansoti B; Gebo KA
    Open Forum Infect Dis; 2023 Dec; 10(12):ofad533. PubMed ID: 38058459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical course of Mpox among HIV-negative and HIV-positive patients: A 2022 cohort of hospitalized patients in Central Europe.
    Kowalski J; Cielniak I; Garbacz-Łagożna E; Cholewińska-Szymańska G; Parczewski M
    J Med Virol; 2023 Oct; 95(10):e29172. PubMed ID: 37861345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Tecovirimat Treatment for Mpox Disease Among People With HIV.
    Aldred B; Lyles RH; Scott JY; Gromer DJ; Aldredge A; Workowski KA; Wiley Z; Titanji BK; Szabo B; Sheth AN; Rebolledo PA; Nguyen ML; Marconi VC; Kelley CF; Kandiah S; Kalapila A; Jacob JT; Hall B; Colasanti JA; Cartwright EJ; Cantos VD
    JAMA Intern Med; 2024 Mar; 184(3):275-279. PubMed ID: 38190312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Mpox Knowledge, Stigma, and Willingness to Vaccinate for Mpox: Cross-Sectional Web-Based Survey Among Sexual and Gender Minorities.
    Torres TS; Silva MST; Coutinho C; Hoagland B; Jalil EM; Cardoso SW; Moreira J; Magalhaes MA; Luz PM; Veloso VG; Grinsztejn B
    JMIR Public Health Surveill; 2023 Jul; 9():e46489. PubMed ID: 37459174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak.
    Essajee NM; Oddo-Moise H; Hagensee ME; Lillis RA; Maffei J; Butler I; Lovett A; Sokol T; Clement ME
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):587-592. PubMed ID: 37424520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV viral load monitoring during monkeypox virus infection among people with HIV.
    Raccagni AR; Mileto D; Galli L; Bruzzesi E; Canetti D; Rizzo A; Bertoni C; Clemente T; Alberton F; Castagna A; Nozza S
    AIDS; 2023 Apr; 37(5):779-783. PubMed ID: 36689645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mpox and HIV: a Narrative Review.
    Saldana CS; Kelley CF; Aldred BM; Cantos VD
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):261-269. PubMed ID: 37178205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mpox in people with advanced HIV infection: a global case series.
    Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
    Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of immunosuppression on the mortality and hospitalization of Monkeypox: a systematic review and meta-analysis of the 2022 outbreak.
    Azzam A; Khaled H; Salem H; Ahmed A; Heniedy AM; Hassan HS; Hassan A; El-Mahdy TS
    Virol J; 2024 Jun; 21(1):130. PubMed ID: 38840177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
    McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
    Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mpox-Specific Immune Responses Elicited by Vaccination or Infection in People With HIV.
    Grüner E; Grossegesse M; Stern D; Ober V; Eser TM; Reiling G; Stirner R; Ibarra G; Postel N; Conca R; Dächert C; Grifoni A; Sette A; Bogner J; Seybold U; Roider J
    J Infect Dis; 2024 Nov; 230(5):1110-1119. PubMed ID: 38478746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.